Kevin B. Jacobsen - Aug 14, 2023 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
EVP - Chief Financial Officer
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Aug 14, 2023
Transactions value $
-$538,096
Form type
4
Date filed
8/16/2023, 04:16 PM
Previous filing
May 17, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock -Sell -$538,096 -3,346 -12.59% $160.82 23,224 Aug 14, 2023 Direct F1, F2
holding CLX Common Stock 45 Aug 14, 2023 By 401(k)
holding CLX Common Stock 25 Aug 14, 2023 By IRA
holding CLX Common Stock 3,145 Aug 14, 2023 By Trust

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 5/4/2023, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.
F2 This transaction was executed in multiple trades at prices ranging from $159.93 to $162.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.